This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dubovsky, J, Daxberger, H, Fritsch, G, Printz, D, Peters, C, Matthes-Martin, S, Gadner, H & Lion, T Kinetic of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: Implications for timely detection of engraftment, graft failure and rejection. Leukemia, (1999). 13, 2060–2069.
Bader, P, Klingebiel, T, Schaudt, A, Theurer-Mainka, U, Handgretinger, R, Niethammer, D & Beck, J Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia, (1999). 13, 2079–2086.
Bader, P, Stoll, K, Huber, S, Geiselhart, A, Handgretinger, R, Niemeyer, C, Einsele, H, Schlegel, PG, Niethammer, D, Beck, J & Klingebiel, T Characterization of lineages specific in patients with acute leukemia and MDS after allogeneic SCT before and after relapse. Br J Haematol, (2000). 108, 761–768.
Lion, T, Daxberger, H, Dubovsky, J, Filipcik, P, Fritsch, G, Printz, D, Peters, C, Matthes-Martin, S, Lawitschka, A & Gadner, H Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation. Leukemia, (2001). 15, 307–310.
Thiede, C, Bornhäuser, M, Oelschlägel, U, Brendel, C, Leo, R, Daxberger, H, Mohr, B, Florek, M, Kroschinsky, F, Geissler, G, Naumann, R, Ritter, M, Prange-Krex, G, Lion, T, Neubauer, A & Ehninger, G Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short-tandem repeat-markers. Leukemia, (2001). 15, 293–302.
Thiede, C & Lion, T Quantitative analysis of chimerism after allogeneic stem cell transplantation using multiplex PCR amplification of short tandem repeat markers and fluorescence detection. Leukemia, (2001). 15, 303–306.
Gonzalez, M, Lopez-Perez, R, Perez-Simon, JA, Garcia-Sanz, R & San Miguel, JF Comments concerning chimerism studies. Leukemia, (2001). 15, 1986–1988.
Beck, O, Koehl, U, Gruettner, HP, Schwabe, D, Klingebiel, T, Seifried, E & Seidl, C The use of chimerism monitoring for adaptive immunotherapy can prevent early graft rejection post allogeneic stem cell transplantation. Haematology J, (2001). 1, 210
Mattsson, J, Uzunel, M, Tammik, L, Aschan, J & Rindgen, O Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation. Leukemia, (2001). 15, 1976–1985.
Gardiner, N, Lawler, M, Riordan, J, DeArce, M & McCann, SR Monitoring of lineage specific chimerism allows early prediction of response following donor lymphocyte infusion for relapsed chronic myeloid leukemia. Bone Marrow Transplant, (1998). 21, 711–719.
Zetterquist, H, Mattsson, J, Uzunel, M, Nasman-Bjork, I, Svenberg, P, Tammik, L, Bayat, G, Winiarski, J & Ringden, O Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia. Bone Marrow Transplant, (2000). 25, 843–851.
Seidl, C, Müller, S, Jäger, O & Seifried, E Sequence analysis and population data of short tandem repeat polymorphisms at loci D8S639 and D11S488. Int J Legal Med, (1999). 112, 355–359.
Thiede, C, Florek, M, Bornhäuser, M, Ritter, M, Mohr, B, Brendel, C, Ehninger, G & Neubauer, A Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant, (1999). 23, 1055–1060.
Hantschel, M, Hausmann, R, Lederer, T, Martus, P & Betz, P Population genetics of nine short tandem repeat (STR) loci – DNA typing using the AmpFISTR Profiler PCR amplification kit. Int J Legal Med, (1999). 112, 293–395.
Binda, S, Borer, UV, Gehrig, C, Hochmeister, M & Budowle, B Swiss Caucasian population data for the STR loci D2S1338 and D19S433 using AmpFISTR SGM Plus PCR amplification kit. Forensic Sci Int, (2000). 108, 117–120.
Scharf, SJ, Smith, AG, Hansen, JA, McFarland, C & Erlich, HA Quantitative determination of bone marrow transplantation engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood, (1995). 85, 1954–1963.
Jones, DA Blood samples: probability of discrimination. J Forensic Sci Soc, (1972). 12, 355–359.
Nei, M & Roychoudhury, AK Sampling variance of heterozygosity and genetic distance. Genetics, (1974). 76, 379–390.
Woolsen, RF Statistical Methods for the Analysis of Biomedical data, Wiley: New York (1987).
Mullokandov, M, Class, I, Achary, PM & Klinger, HP Assignment of ACTBP8 (alias ACTBP2) within close to human chromosome band 6q13 using a radiation hybrid panel. Cytogenet Cell Genet, (1997). 78, 46–47.
Klingebiel, T, Niethammer, D, Dietz, K & Bader, P Progress in chimerism analysis in childhood malignancies: the dilemma of biostatistical considerations and ethical implications. Leukemia, (2001). 15, 1989–1991.
Choi, SJ, Lee, KH, Lee, JH, Kim, S, Chung, HJ, Lee, JS, Park, CJ, Chi, HS & Kim, WK Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant, (2000). 26, 327–332.
Shimoni, A & Nagler, A Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations. Leukemia, (2001). 15, 1967–1975.
Lion, T & Muller-Berat, N Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal techniques for testing in different clinical–biological situations. Leukemia, (1999). 13, 2059
Lion, T Chimerism testing after allogeneic stem cell transplantation: Importance of timing and optimal techniques for testing in different clinical–biological situations. Leukemia, (2001). 15, 292
Lion, T & Muller-Berat, N Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal techniques for testing in different clinical–biological situations. Leukemia, (2001). 15, 1966
Polymeropoulos, MH, Xiao, H, Rath, DS & Merril, CR Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res, (1991). 19, 195
Polymeropoulos, MH, Xiao, H, Rath, DS & Merril, CR Tetranucleotide repeat polymorphism at the human prostatic acid phosphatase (ACPP) gene. Nucleic Acids Res, (1991). 19, 4792
Acknowledgements
We thank M Kilp, A Brinkmann and S Grohal for excellent technical assistance. This project was supported by ‘Frankfurter Stiftung für Krebskranke Kinder’ and by ‘Paul und Ursula Klein-Stiftung’. We are grateful for the technical and material support of Dr GL Selders, Dr S Günther and T Scheidereit (Applied Biosystems).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koehl, U., Beck, O., Esser, R. et al. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience. Leukemia 17, 232–236 (2003). https://doi.org/10.1038/sj.leu.2402760
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402760
Keywords
This article is cited by
-
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
Bone Marrow Transplantation (2013)
-
Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia
Annals of Hematology (2013)
-
Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
Annals of Hematology (2013)
-
Quantitative monitoring of multi-donor chimerism: a systematic, validated framework for routine analysis
Bone Marrow Transplantation (2010)
-
Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility
Bone Marrow Transplantation (2007)